ArticleJBMR plus2024
On-time denosumab dosing recovered rapidly during the COVID-19 pandemic, yet remains suboptimal.
Anna M Rzepka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleJBMR plus2024
Anna M Rzepka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.